Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patients

To report the efficacy, safety, and quality of life (QoL) on generic and innovator ibrutinib in Indian CLL patients. This was a single centre, prospective study of treatment-naive (TN), and relapsed/refractory (R/R) CLL patients receiving ibrutinib in India. The choice of innovator or generic ibruti...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Indian J Hematol Blood Transfus
Egile Nagusiak: Singh, Charanpreet, Jindal, Nishant, Youron, Padma, Malhotra, Pankaj, Prakash, Gaurav, Khadwal, Alka, Jain, Arihant, Sreedharanunni, Sreejesh, Sachdeva, Man Updesh Singh, Naseem, Shano, Varma, Neelam, Varma, Subhash, Lad, Deepesh P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer India 2020
Gaiak:
Short Communication
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8012457/
https://ncbi.nlm.nih.gov/pubmed/33867740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-020-01378-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak